Clin Mol Hepatol.
2023 Apr;29(2):401-403. 10.3350/cmh.2023.0062.
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
- Affiliations
-
- 1Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
- KMID: 2541428
- DOI: http://doi.org/10.3350/cmh.2023.0062
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
- Diagnosis of Non-alcoholic Fatty Liver Disease
- Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
- Diagnosis of Non-Alcoholic Fatty Liver Disease Based on Clinical and Laboratory Data
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
